Bausch + Lomb Corporation (NYSE: BLCO) closed the day trading at $18.60 down -2.77% from the previous closing price of $19.13. In other words, the price has decreased by -$0.53 from its previous closing price. On the day, 679975 shares were traded. BLCO stock price reached its highest trading level at $19.01 during the session, while it also had its lowest trading level at $18.42.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
For a better understanding of BLCO, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.79 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 56.05. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.70. In the meantime, Its Debt-to-Equity ratio is 0.36 whereas as Long-Term Debt/Eq ratio is at 0.36.
Upgrades & Downgrades
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 01 when Bausch Health Companies Inc. sold 4,550,357 shares for $17.05 per share. The transaction valued at 77,606,339 led to the insider holds 310,449,643 shares of the business.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLCO now has a Market Capitalization of 6.15B and an Enterprise Value of 8.23B. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.71 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 2.16 whereas that against EBITDA is 20.53.
Stock Price History:
Over the past 52 weeks, BLCO has reached a high of $19.96, while it has fallen to a 52-week low of $12.20. The 50-Day Moving Average of the stock is 17.30, while the 200-Day Moving Average is calculated to be 16.30.
Over the past 3-months, BLCO traded about 391.78K shares per day on average, while over the past 10 days, BLCO traded about 729.97k shares per day. A total of 350.00M shares are outstanding, with a floating share count of 349.08M. Insiders hold about 0.20% of the company’s shares, while institutions hold 12.80% stake in the company. Shares short for BLCO as of Apr 27, 2023 were 6.47M with a Short Ratio of 6.47M, compared to 7.1M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.85% and a Short% of Float of 16.25%.
Current recommendations for the stock of the company come from 6 analysts. The consensus estimate for the next quarter is $0.31, with high estimates of $0.34 and low estimates of $0.28.
Analysts are recommending an EPS of between $1.13 and $0.97 for the fiscal current year, implying an average EPS of $1.05. EPS for the following year is $1.31, with 7 analysts recommending between $1.57 and $1.11.
A total of 8 analysts have provided revenue estimates for BLCO’s current fiscal year. The highest revenue estimate was $5.33B, while the lowest revenue estimate was $5.22B, resulting in an average revenue estimate of $5.3B. In the same quarter a year ago, actual revenue was $5.1B, up 3.90% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $5.55B in the next fiscal year. The high estimate is $5.61B and the low estimate is $5.41B. The average revenue growth estimate for next year is up 4.60% from the average revenue estimate for this year.